Northern Trust Corp Vertex Pharmaceuticals Inc Transaction History

Northern Trust Corp

  • $600 Billion
  • Q3 2024

A detailed history of Northern Trust Corp transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Northern Trust Corp holds 2,365,992 shares of VRTX stock, worth $1.1 Billion. This represents 0.18% of its overall portfolio holdings.

Number of Shares
2,365,992
Previous 2,533,904 6.63%
Holding current value
$1.1 Billion
Previous $1.19 Billion 7.35%
% of portfolio
0.18%
Previous 0.2%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$460.0 - $505.78 $77.2 Million - $84.9 Million
-167,912 Reduced 6.63%
2,365,992 $1.1 Billion
Q2 2024

Aug 14, 2024
SELL
$392.81 - $485.53 $17.5 Million - $21.6 Million
-44,533 Reduced 1.73%
2,533,904 $1.19 Billion
Q1 2024

May 14, 2024
SELL
$407.69 - $446.08 $41.6 Million - $45.6 Million
-102,160 Reduced 3.81%
2,578,437 $1.08 Billion
Q4 2023

Feb 13, 2024
SELL
$343.0 - $410.68 $45.6 Million - $54.6 Million
-132,966 Reduced 4.73%
2,680,597 $1.09 Billion
Q3 2023

Nov 13, 2023
BUY
$338.18 - $362.46 $44.5 Million - $47.7 Million
131,539 Added 4.9%
2,813,563 $978 Million
Q2 2023

Aug 11, 2023
SELL
$314.42 - $351.91 $29.8 Million - $33.3 Million
-94,671 Reduced 3.41%
2,682,024 $944 Million
Q1 2023

May 15, 2023
SELL
$283.23 - $323.1 $21.2 Million - $24.2 Million
-74,864 Reduced 2.63%
2,776,695 $875 Million
Q4 2022

Feb 13, 2023
SELL
$285.76 - $321.48 $10.4 Million - $11.7 Million
-36,439 Reduced 1.26%
2,851,559 $823 Million
Q3 2022

Nov 14, 2022
SELL
$273.83 - $305.53 $13.4 Million - $15 Million
-48,936 Reduced 1.67%
2,887,998 $836 Million
Q2 2022

Aug 12, 2022
BUY
$234.96 - $292.55 $11 Million - $13.7 Million
46,981 Added 1.63%
2,936,934 $828 Million
Q1 2022

May 13, 2022
SELL
$221.42 - $260.97 $4.07 Million - $4.8 Million
-18,399 Reduced 0.63%
2,889,953 $754 Million
Q4 2021

Feb 08, 2022
SELL
$177.01 - $223.45 $15.2 Million - $19.2 Million
-86,138 Reduced 2.88%
2,908,352 $639 Million
Q3 2021

Nov 15, 2021
BUY
$181.39 - $202.99 $3.93 Million - $4.4 Million
21,674 Added 0.73%
2,994,490 $543 Million
Q2 2021

Aug 13, 2021
SELL
$187.49 - $221.1 $1.02 Million - $1.2 Million
-5,434 Reduced 0.18%
2,972,816 $599 Million
Q1 2021

May 12, 2021
SELL
$207.02 - $241.31 $9.16 Million - $10.7 Million
-44,254 Reduced 1.46%
2,978,250 $640 Million
Q4 2020

Feb 11, 2021
SELL
$207.01 - $276.09 $15.6 Million - $20.8 Million
-75,401 Reduced 2.43%
3,022,504 $714 Million
Q3 2020

Nov 16, 2020
BUY
$255.65 - $303.1 $30.7 Million - $36.4 Million
119,997 Added 4.03%
3,097,905 $843 Million
Q2 2020

Aug 14, 2020
BUY
$225.48 - $295.8 $26.6 Million - $34.9 Million
117,949 Added 4.12%
2,977,908 $865 Million
Q1 2020

May 14, 2020
BUY
$199.77 - $247.81 $3.64 Million - $4.52 Million
18,222 Added 0.64%
2,859,959 $681 Million
Q4 2019

Feb 14, 2020
SELL
$166.71 - $223.91 $18.4 Million - $24.7 Million
-110,483 Reduced 3.74%
2,841,737 $622 Million
Q3 2019

Nov 13, 2019
BUY
$166.23 - $187.09 $1.4 Million - $1.58 Million
8,440 Added 0.29%
2,952,220 $500 Million
Q2 2019

Aug 13, 2019
BUY
$164.61 - $190.37 $5.43 Million - $6.28 Million
33,009 Added 1.13%
2,943,780 $540 Million
Q1 2019

May 13, 2019
BUY
$163.73 - $194.7 $5.24 Million - $6.23 Million
31,978 Added 1.11%
2,910,771 $535 Million
Q4 2018

Feb 12, 2019
BUY
$151.91 - $192.21 $15 Million - $18.9 Million
98,585 Added 3.55%
2,878,793 $477 Million
Q3 2018

Nov 14, 2018
SELL
$167.73 - $192.74 $3.81 Million - $4.38 Million
-22,732 Reduced 0.81%
2,780,208 $536 Million
Q2 2018

Sep 18, 2018
SELL
$145.72 - $169.96 $2.37 Million - $2.76 Million
-16,247 Reduced 0.58%
2,802,940 $476 Million
Q2 2018

Aug 14, 2018
BUY
$145.72 - $169.96 $1.39 Million - $1.63 Million
9,563 Added 0.34%
2,819,187 $479 Million
Q1 2018

May 09, 2018
SELL
$151.6 - $177.13 $5.11 Million - $5.97 Million
-33,696 Reduced 1.19%
2,809,624 $458 Million
Q4 2017

Feb 14, 2018
SELL
$137.28 - $155.55 $6.87 Million - $7.79 Million
-50,060 Reduced 1.73%
2,843,320 $426 Million
Q3 2017

Nov 13, 2017
BUY
$148.13 - $162.24 $429 Million - $469 Million
2,893,380
2,893,380 $440 Million

Others Institutions Holding VRTX

# of Institutions
1,724
Shares Held
222M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $119B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email